Phase 2 study of Bevacizumab Beyond Progression treatment in patients with advanced non-squamous non-small-cell Lung cancer
Phase 2
Recruiting
- Conditions
- advanced non-squamous non-small-cell Lung cancer
- Registration Number
- JPRN-UMIN000007854
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
Not provided
Exclusion Criteria
(1)symptoms due to brain metastasis (2)hemoptysis (3)significant hemosputum (4)radiation therapy to chest region (5)significant infectious disease (6)severe conplication (7)uncontrollable acsites, plueral effusion, cardiac effusion (8)active multiple cancer (9)severe drug allergy (10)unnable to administer vitamin B12.reject to Vitamin B12 (11)interstitial pneumoniae or pulmonary fibrosis (12)uncontrollable hypertension (13)uncontrollable gastrointestinal tract ulcer (14)perforation of the digestive tract or experimental operation (15)doctors estimated innadequated
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method